Back
NovoCure Ltd. Stock Price Chart
99.6% Win Rate Across 508 Picks (Third-Party Audited)
See how Decentralized Masters' system identifies 10x-100x opportunities before Coinbase. Watch free training.
Sell
44
NVCR
NovoCure Ltd.
Last Price:
$13.46
Seasonality Move:
1.75%
7 Day Trial
ALL ACCESS PASS
$
7
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets-
The current trend is moderately bearish and NVCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
NovoCure Ltd. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.73 | Buy |
| 20-day SMA: | 13.73 | Buy |
| 50-day SMA: | 12.76 | Buy |
| 200-day SMA: | 14.43 | Sell |
| 8-day EMA: | 13.76 | Buy |
| 20-day EMA: | 13.61 | Buy |
| 50-day EMA: | 13.23 | Buy |
| 200-day EMA: | 14.67 | Sell |
NovoCure Ltd. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.24 | Buy |
| Relative Strength Index (14 RSI): | 57.63 | Buy |
| Chaikin Money Flow: | 704159 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
NovoCure Ltd. Technical Analysis
| Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 08 | 09 | 12 | 13 | 14 | 15 | 16 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NovoCure Ltd. Stock
Is NovoCure Ltd. Stock a Buy?
-
NovoCure Ltd. share price is 14.19 while NVCR 8-day simple moving average is 13.73, which is a Buy signal.
-
The stock price of NVCR is 14.19 while NovoCure Ltd. 20-day SMA is 13.73, which makes it a Buy.
-
NovoCure Ltd. 50-day simple moving average is 12.76 while NVCR share price is 14.19, making it a Buy technically.
-
NVCR stock price is 14.19 and NovoCure Ltd. 200-day simple moving average is 14.43, creating a Sell signal.
NVCR Technical Analysis vs Fundamental Analysis
Sell
44
NovoCure Ltd. (NVCR)
is a Sell
Is NovoCure Ltd. a Buy or a Sell?
-
NovoCure Ltd. stock is rated a SellThe current NovoCure Ltd. [NVCR] share price is $14.19. The Score for NVCR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
NovoCure Ltd. Stock Info
Market Cap:
1.5B
Price in USD:
14.19
Share Volume:
1M
NovoCure Ltd. 52-Week Range
52-Week High:
27.32
52-Week Low:
10.70
Sell
44
NovoCure Ltd. (NVCR)
is a Sell
NovoCure Ltd. Share Price Forecast
-
What is the NovoCure Ltd. stock price today?The NovoCure Ltd. stock price is 14.19 USD today.
-
Will NVCR stock go up or go down?NovoCure Ltd.> share price is forecast to RISE/FALL based on technical indicators
-
Is NovoCure Ltd. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovoCure Ltd. is overvalued.
Is NovoCure Ltd. Stock a Buy?
-
NovoCure Ltd. share price is 14.19 while NVCR 8-day exponential moving average is 13.76, which is a Buy signal.
-
The stock price of NVCR is 14.19 while NovoCure Ltd. 20-day EMA is 13.61, which makes it a Buy.
-
NovoCure Ltd. 50-day exponential moving average is 13.23 while NVCR share price is 14.19, making it a Buy technically.
-
NVCR stock price is 14.19 and NovoCure Ltd. 200-day simple moving average is 14.67, creating a Sell signal.
Fundamental Analysis of NovoCure Ltd.
Is NovoCure Ltd. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.36 per share.
Technical Analysis of NovoCure Ltd.
Should I short NovoCure Ltd. stock?
-
NVCR Moving Average Covergence Divergence (MACD) indicator is 0.24, suggesting NovoCure Ltd. is a Buy
-
NovoCure Ltd. Relative Strength Index (RSI) is 57.63, which suggest NovoCure Ltd. is overbought
-
The Bollinger Bands (25) for NovoCure Ltd. is ( - ), which suggest NovoCure Ltd. is a Buy
-
The Bollinger Bands (100) for NovoCure Ltd. is ( - ), which suggest NovoCure Ltd. is a Buy
* NovoCure Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.